FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1995325820> ?p ?o ?g. }

• W1995325820 endingPage "457" @default.
• W1995325820 startingPage "451" @default.
• W1995325820 abstract "<i>Background:</i> Scarring is one of the steps of excessive wound healing, causing dysfunction of the involved tissues and clinically poor cosmetics. The aim of this study was to examine the effect of a highly selective cyclooxygenase-2 (COX-2) inhibitor on renal scar formation in experimental pyelonephritis. <i>Materials and Methods:</i> Four groups of 10 Balb/C mice were formed. In groups I and II following the inoculation of lipopolysaccharide (LPS) into both kidneys, 0.18 and 0.36 mg/day of rofecoxib was given respectively via intraperitoneal route for 5 days. No medication was applied following physiological saline solution injection to both kidneys of the mice in group III (negative control group). After group IV’s LPS inoculation on the first day, saline solution (1 ml/day) was given intraperitoneally for 5 days (positive control group). Following the exposure of both kidneys, LPS of <i>Escherichia coli</i> (5 mg/kg) was injected into the kidneys of groups I, II, and IV. In group III, saline solution (0.1 ml) was used instead of LPS. Three days after the inoculation of LPS, solutions containing 0.18 and 0.36 mg of COX-2 inhibitor were given intraperitoneally for 5 days in groups I and II. No medication was used for the mice in group III. Six weeks after the inoculation of LPS and saline solution, all mice were humanely euthanized. Bilateral nephrectomies were done on each group of mice, and histopathological examination was performed. <i>Results:</i> Inoculation of LPS into the renal parenchyma caused pyelonephritis and scar formation in all groups. The degree of pyelonephritis and scar formation was lesser in groups in which COX-2 inhibitors were used. The degree of scar formation was lesser in group II, in which 0.36 mg more of COX-2 inhibitor was used than in group I (0.18 mg of COX-2 inhibitor). <i>Conclusion:</i> In our study model, direct inoculation of LPS to kidneys caused experimentally induced pyelonephritis. Renal scar formation was effectively prevented through the utilization of rofecoxib at 0.36-mg doses." @default.
• W1995325820 created "2016-06-24" @default.
• W1995325820 creator A5003038798 @default.
• W1995325820 creator A5008413437 @default.
• W1995325820 creator A5018469954 @default.
• W1995325820 creator A5052226132 @default.
• W1995325820 creator A5061271111 @default.
• W1995325820 creator A5065421365 @default.
• W1995325820 creator A5078020127 @default.
• W1995325820 date "2006-01-01" @default.
• W1995325820 modified "2023-10-17" @default.
• W1995325820 title "Effect of a Selective Cyclooxygenase-2 Inhibitor on Renal Scarring" @default.
• W1995325820 cites W105397550 @default.
• W1995325820 cites W122911005 @default.
• W1995325820 cites W1489729973 @default.
• W1995325820 cites W1828786787 @default.
• W1995325820 cites W1964011492 @default.
• W1995325820 cites W1965551332 @default.
• W1995325820 cites W1969384951 @default.
• W1995325820 cites W1976289701 @default.
• W1995325820 cites W1982102893 @default.
• W1995325820 cites W2004638047 @default.
• W1995325820 cites W2008900960 @default.
• W1995325820 cites W2025032647 @default.
• W1995325820 cites W2030615548 @default.
• W1995325820 cites W2030714517 @default.
• W1995325820 cites W2038410983 @default.
• W1995325820 cites W2052249817 @default.
• W1995325820 cites W2063261449 @default.
• W1995325820 cites W2067628390 @default.
• W1995325820 cites W2068439200 @default.
• W1995325820 cites W2083999558 @default.
• W1995325820 cites W2084334139 @default.
• W1995325820 cites W2084942092 @default.
• W1995325820 cites W2095060266 @default.
• W1995325820 cites W2098923926 @default.
• W1995325820 cites W2125471714 @default.
• W1995325820 cites W2165000537 @default.
• W1995325820 cites W2236967318 @default.
• W1995325820 cites W2293977658 @default.
• W1995325820 cites W2316952049 @default.
• W1995325820 cites W2324937429 @default.
• W1995325820 cites W2325727928 @default.
• W1995325820 cites W2330496155 @default.
• W1995325820 cites W2334648167 @default.
• W1995325820 cites W2401936043 @default.
• W1995325820 cites W2407253326 @default.
• W1995325820 cites W2411981312 @default.
• W1995325820 cites W2414420827 @default.
• W1995325820 cites W2415485292 @default.
• W1995325820 cites W2416535632 @default.
• W1995325820 cites W2440745587 @default.
• W1995325820 cites W2466294236 @default.
• W1995325820 cites W2988820293 @default.
• W1995325820 cites W30268790 @default.
• W1995325820 cites W3147046978 @default.
• W1995325820 cites W347227128 @default.
• W1995325820 cites W77703805 @default.
• W1995325820 cites W1980858407 @default.
• W1995325820 cites W2069208314 @default.
• W1995325820 doi "https://doi.org/10.1159/000095088" @default.
• W1995325820 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16912484" @default.
• W1995325820 hasPublicationYear "2006" @default.
• W1995325820 type Work @default.
• W1995325820 sameAs 1995325820 @default.
• W1995325820 citedByCount "7" @default.
• W1995325820 countsByYear W19953258202014 @default.
• W1995325820 countsByYear W19953258202015 @default.
• W1995325820 countsByYear W19953258202016 @default.
• W1995325820 crossrefType "journal-article" @default.
• W1995325820 hasAuthorship W1995325820A5003038798 @default.
• W1995325820 hasAuthorship W1995325820A5008413437 @default.
• W1995325820 hasAuthorship W1995325820A5018469954 @default.
• W1995325820 hasAuthorship W1995325820A5052226132 @default.
• W1995325820 hasAuthorship W1995325820A5061271111 @default.
• W1995325820 hasAuthorship W1995325820A5065421365 @default.
• W1995325820 hasAuthorship W1995325820A5078020127 @default.
• W1995325820 hasConcept C126322002 @default.
• W1995325820 hasConcept C181199279 @default.
• W1995325820 hasConcept C185592680 @default.
• W1995325820 hasConcept C2777397205 @default.
• W1995325820 hasConcept C2778754761 @default.
• W1995325820 hasConcept C2779689624 @default.
• W1995325820 hasConcept C2780091579 @default.
• W1995325820 hasConcept C2780159080 @default.
• W1995325820 hasConcept C55493867 @default.
• W1995325820 hasConcept C71924100 @default.
• W1995325820 hasConcept C98274493 @default.
• W1995325820 hasConceptScore W1995325820C126322002 @default.
• W1995325820 hasConceptScore W1995325820C181199279 @default.
• W1995325820 hasConceptScore W1995325820C185592680 @default.
• W1995325820 hasConceptScore W1995325820C2777397205 @default.
• W1995325820 hasConceptScore W1995325820C2778754761 @default.
• W1995325820 hasConceptScore W1995325820C2779689624 @default.
• W1995325820 hasConceptScore W1995325820C2780091579 @default.
• W1995325820 hasConceptScore W1995325820C2780159080 @default.
• W1995325820 hasConceptScore W1995325820C55493867 @default.
• W1995325820 hasConceptScore W1995325820C71924100 @default.

• next